Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
6.51
+0.15 (2.36%)
At close: Jul 14, 2026, 4:00 PM EDT
6.52
+0.01 (0.15%)
Pre-market: Jul 15, 2026, 7:00 AM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $1.68 billion as of July 15, 2026. Its market cap has increased by 167.22% in one year.
Market Cap
1.68B
Enterprise Value
1.83B
1-Year Change
167.22%
Ranking
Category
Stock Price
$6.51
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.68B, a decrease of -76.76%. That is a compound annual growth rate of -22.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.68B | 102.26% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.73B |
| Damora Therapeutics | 1.72B |
| Taysha Gene Therapies | 1.72B |
| Fortrea Holdings | 1.70B |
| MoonLake Immunotherapeutics | 1.69B |
| Vir Biotechnology | 1.67B |
| MapLight Therapeutics | 1.66B |
| Immunocore Holdings | 1.65B |